Track & Trace Solutions for Direct-to-Patient Delivery

Building a comprehensive track-and-trace system for medicines, which is aligned with the European Falsified Medicines Directive and to ensure compliance is a must in today's environment.

Pharmacies, hospitals, HCPs, caregivers, and patients now expect a completely secure and traceable delivery process, which requires buy-in from pharmaceutical companies and distributors involved in the supply chain of Investigational Medicinal Products (IMP), SKU's and unique doses.

This webinar provides an overview of the key trends and developments to improve the security of drug delivery direct-2-patient in 2021. 

Key discussion points: 

• A global overview of regulations on traceability of medical devices and medicines 
• Technical challenges when tracking medicinal products along the product life cycle, from clinical trials to post marketing authorization 
• What does the future look like? The potential of delivering Direct-to-Patient unique doses

This session was originally broadcast as part of the CPhI Webinar Series.